权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Regulation of DNA replication kinetics by BRCA2 after DNA damage

DNA 损伤后 BRCA2 对 DNA 复制动力学的调节

基本信息

批准号：
10278027
负责人：
Bing Xia
金额：
$ 34.48万
依托单位：
RBHS -CANCER INSTITUTE OF NEW JERSEY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10278027
关键词：
Aftercare Alleles BRCA2 gene Binding Breast Breast Cancer Cell Breast Cancer Model CDC45L gene Cancer Etiology Cell Cycle Checkpoint Cells Chemotherapy and/or radiation Chromatin Cisplatin Complex Coupled DNA DNA Damage DNA Double Strand Break DNA Primase DNA Repair DNA Replication Damage DNA Replication Factor DNA biosynthesis DNA replication fork DNA-Directed DNA Polymerase Defect Development Double Strand Break Repair Family Genes Genome Genome Stability Genomic Instability Germ-Line Mutation Induced Mutation Kinetics Lead MCM10 gene MCM2 gene Malignant Neoplasms Malignant neoplasm of ovary Mammals Mammary Tumorigenesis Maps Mediating Mitotic Modality Mutant Strains Mice Mutation Ovarian Pancreas Pathway interactions Pattern Phenotype Physiological Platinum Play Polymerase Process Prognosis Proteins Radiation Radio Regulation Relapse Replication Error Replication Initiation Replication Origin Reporting Resistance Role S Phase Salts Second Primary Cancers Site Testing Time Travel Tumor Suppression Tumor Suppressor Proteins Xenograft Model base cancer cell cancer therapy conditional knockout design genome integrity helicase homologous recombination inhibitor/antagonist insight member mutant novel strategies overexpression prevent radiation response radioresistant recruit repaired replication stress response skip lesion triple-negative invasive breast carcinoma tumor tumorigenesis

项目摘要

Germline mutations in BRCA2 predispose carriers to breast, ovarian, pancreatic, and other cancers. The gene encodes a very large protein that plays critical roles in genome integrity control by promoting homologous recombination (HR)-mediated repair of DNA double strand breaks (DSBs), DNA damage-induced cell cycle checkpoint, and stability of stalled DNA replication forks, etc. Besides, BRCA2 may play a direct role in DNA replication, as its mutant cells have long been known to have the so-called radio-resistant DNA synthesis (RDS) phenotype, which reflects a defect in the intra-S phase checkpoint, a mechanism that slows down DNA replication after DNA damage presumably to allow time for DNA repair and prevent replication of damage DNA. However, the potential role of BRCA2 in DNA replication initiation or elongation has not been defined. In our preliminary studies, we found that BRCA2 interacts with an essential DNA replication factor, MCM10, and that this interaction restrains replication fork progression, promotes fork stalling and sustains origin firing after DNA damage. We hypothesize that BRCA2 regulates DNA replication kinetics after DNA damage through its interaction with MCM10 and that a dysregulation of replication kinetics after DNA damage, or intra-S phase checkpoint defect, leads to increased mutation rate, cancer development and therapy resistance. We propose 3 specific aims to test the hypotheses. In Aim 1, we will define the mechanisms of BRCA2 function in DNA replication kinetics after DNA damage. In Aim 2, we will determine the role of the BRCA2-MCM10 interaction in DNA replication fidelity and cancer cell response to DNA damaging therapies. In Aim 3, we will determine the role of BRCA2-MCM10 interaction in spontaneous and radiation-induced tumor development. Our findings and proposed studies will elucidate key mechanisms of BRCA2 function in DNA replication, provide new insights into the regulation of replication kinetics after DNA damage, and define the impact of RDS and replication kinetics dysregulation on cancer development and tumor relapse after radiation and chemotherapy.

BRCA2的种系突变使携带者易患乳腺癌、卵巢癌、胰腺癌和其他癌症。的基因